Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-633-0 | CAS number: 705279-64-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 13 Nov - 22 Nov 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP - Guideline study. According to the ECHA guidance document "Practical guide 6: How to report read-across and categories (March 2010)", the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Ministerium für Umwelt und Naturschutz, Landwirtschaft und Verbraucherschutz des Landes Nordrhein-Westfalen, Düsseldorf, Germany
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 97593-30-1 (C12)
- IUPAC Name:
- 97593-30-1 (C12)
- Details on test material:
- - Name of test material (as cited in study report): only trade name given
- Chemical name: acetylated glyceride-mixture
- Physical state: clear yellowish liquid
- Analytical purity: 100%
- Purity test date: 15 Oct 2007
- Lot/batch No.: CH70920C
- Expiration date of the lot/batch: 20 Sep 2008
- Stability under test conditions: The batch used was analytically examined for identity prior to study initiation and was approved for use for the test period. A stability test in the solvent did not reveal significant degradation of the active ingredient.
- Storage condition of test material: at room temperature
Constituent 1
Method
- Target gene:
- his operon
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- 50, 158, 500, 1581 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO (0.1 mL/plate)
- Justification for choice of solvent/vehicle: The solvent used was chosen out of the following solvents, in the order given: water, DMSO, methanol, ethanol, acetone, ethylene glycol dimethylether (EGDE), and DMF according to information given by the sponsor. The order of these solvents is based on their bacteriotoxic effects in preincubation experiments.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: -S9 (µg/plate, strain): sodium azide (10, TA1535); Nitrofurantoin (0.2, TA100); 4-nitro-1,2-phenylene diamine (0.5 and 10, TA98 and TA1537, respectively); Mitomycin C (0.2, TA102 [plate incorporation]); cumene hydroperoxide (50, TA102 [preincubation])
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: +S9 (µg/plate, strain): 2-aminoanthracene (3, all strains)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
First experiment: in agar (plate incorporation)
Second experiment: preincubation
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3 in each experiment (plate incorporation and preincubation)
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency and/or reduction in background growth - Evaluation criteria:
- A reproducible and dose-related increase in mutant counts of at least one strain is considered to be a positive result. For TA 1535, TA 100 and TA 98 this increase should be about twice that of negative controls, whereas for TA 1537, at least a threefold increase should be reached. For TA 102 an increase of about 100 mutants should be reached. Otherwise, the result is evaluated as negative. However, these guidelines may be overruled by good scientific judgement.
In case of questionable results, investigations should continue, possibly with modifications, until a final evaluation is possible. - Statistics:
- Mean values and standard deviation were calculated.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- TA1535, TA98 and TA100: at 1581 µg/plate and above (with S9); TA1537: at 500 µg/plate and above (with S9)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1581 µg/plate and above (with S9)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: At 1581 µg/plate, the substance started to precipitate.
COMPARISON WITH HISTORICAL CONTROL DATA:
The negative controls (DMSO) were within the expected range and the positive controls showed sufficient effects when compared to the testing laboratory's historical negative and positive control data presented in the study report for the preceding 10 years.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
Cytotoxic effects, as assessed by a reduction in the number of revertants per plate and/or reduction in background lawn, were observed in the plate incorporation assay in:
TA1535 at 5000 µg/plate with metabolic activation
TA100 at 1581 µg/plate and above with metabolic activation
TA1537 at 1581 µg/plate and above with metabolic activation
In the preincubation assay, cytotoxic effects were observed in:
TA1535 at 1581 µg/plate and above with metabolic activation
TA100 at 1581 µg/plate and above with metabolic activation
TA1537 at 500 µg/plate and above with metabolic activation, and at 5000 µg/plate without metabolic activation
TA98 at 1581 µg/plate and above with metabolic activation
TA102 at 1581 µg/plate and above with metabolic activation - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1. Test results of first experiment (plate incorporation).
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
|
|
TA 100 |
TA1535 |
TA102 |
TA98 |
TA1537 |
– |
DMSO |
130 ± 19 |
11 ± 3 |
263 ± 5 |
28 ± 6 |
7 ± 2 |
– |
50 |
147 ± 12 |
8 ± 2 |
255 ± 6 |
21 ± 6 |
9 ± 1 |
– |
158 |
159 ± 14 |
11 ± 4 |
215 ± 35 |
19 ± 5 |
7 ± 2 |
– |
500 |
141 ± 15 |
10 ± 2 |
235 ± 9 |
26 ± 2 |
6 ± 1 |
– |
1581 |
142 ± 14P |
11 ± 1P |
253 ± 28P |
24 ± 7P |
5 ± 2P |
– |
5000 |
143 ± 20P |
9 ± 3P |
231 ± 16P |
23 ± 9P |
5 ± 2P |
Positive controls, –S9 |
Name |
NF |
Na-azide |
MMC |
4-NPDA |
4-NPDA |
Concentrations (μg/plate) |
0.2 |
10 |
0.2 |
0.5 |
10 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
387 ± 16 |
527 ± 24 |
517 ± 16 |
137 ± 5 |
88 ± 8 |
|
+ |
DMSO |
184 ± 4 |
12 ± 2 |
340 ± 39 |
35 ± 8 |
12 ± 3 |
+ |
50 |
187 ± 6 |
12 ± 4 |
333 ± 13 |
31 ± 6 |
12 ± 4 |
+ |
158 |
198 ± 20 |
11 ± 3 |
348 ± 8 |
33 ± 7 |
10 ± 1 |
+ |
500 |
176 ± 8 |
13 ± 5 |
311 ± 8 |
30 ± 6 |
10 ± 1 |
+ |
1581 |
156 ± 12P* |
10 ± 5P |
322 ± 45P |
24 ± 5P |
6 ± 2P* |
+ |
5000 |
151 ± 8P* |
7 ± 3P* |
300 ± 27P |
27 ± 11P |
4 ± 1P* |
Positive controls, +S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
3 |
3 |
3 |
3 |
3 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
2434 ± 260 |
149 ± 26 |
847 ± 80 |
1340 ± 110 |
446 ± 46 |
NF = nitrofurantoin
Na-azide = sodium azide
MMC = mitomycin C
4-NPDA = 4-nitro-1,2-phenylene diamine
2AA = 2-aminoanthracene
P = precipitate
* = cytotoxicity
Table 2. Test results of second experiment (preincubation).
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± Standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
|
|
TA 100 |
TA1535 |
TA102 |
TA98 |
TA1537 |
– |
DMSO |
131 ± 5 |
12 ± 2 |
266 ± 4 |
16 ± 3 |
8 ± 1 |
– |
50 |
112 ± 16 |
9 ± 1 |
268 ± 6 |
17 ± 2 |
6 ± 1 |
– |
158 |
113 ± 17 |
9 ± 1 |
266 ± 13 |
13 ± 4 |
6 ± 1 |
– |
500 |
111 ± 12 |
8 ± 1 |
263 ± 12 |
15 ± 4 |
7 ± 3 |
– |
1581 |
104 ± 14 |
8 ± 2 |
222 ± 28 |
16 ± 7 |
6 ± 2 |
– |
5000 |
99 ± 3P |
7 ± 1P |
254 ± 16P |
12 ± 5P |
0 ± 0BP |
Positive controls, –S9 |
Name |
NF |
Na-azide |
Cumene |
4-NPDA |
4-NPDA |
Concentrations (μg/plate) |
0.2 |
10 |
0.2 |
0.5 |
10 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
560 ± 17 |
701 ± 27 |
503 ± 27 |
137 ± 5 |
102 ± 6 |
|
+ |
DMSO |
199 ± 6 |
12 ± 0 |
354 ± 16 |
27 ± 0 |
8 ± 2 |
+ |
50 |
211 ± 9 |
11 ± 3 |
320 ± 22 |
25 ± 5 |
10 ± 1 |
+ |
158 |
197 ± 33 |
12 ± 3 |
334 ± 31 |
22 ± 4 |
6 ± 1 |
+ |
500 |
100 ± 14 |
9 ± 2 |
267 ± 21 |
16 ± 3 |
5 ± 2 |
+ |
1581 |
73 ± 5B |
7 ± 2 |
178 ± 5B |
10 ± 4B |
1 ± 1BP |
+ |
5000 |
71 ± 14BP |
3 ± 2BP |
156 ± 22BP |
1 ± 2BP |
0 ± 0BP |
Positive controls, +S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
3 |
3 |
3 |
3 |
3 |
|
Mean No. of colonies/plate (average of 3 ± SD) |
2021 ± 235 |
176 ± 19 |
594 ± 47 |
1719 ± 168 |
178 ± 36 |
NF = nitrofurantoin
Na-azide = sodium azide
Cumene = cumene hydroperoxide
4-NPDA = 4-nitro-1,2-phenylene diamine
2AA = 2-aminoanthracene
B = background lawn reduced
P = precipitate
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.